ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

HARRY SCHWERDTFEGER MD

At A Glance: This Prescriber in 2012

Psychosomatic Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,189Medicare Part D Prescriptions Filled, Including Refills
$1.75M Total Retail Price of All Prescriptions
624 Patients Receiving at Least One Drug in Part D
17%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
ABILIFY 1,009 126 10
RISPERIDONE 520 71
TRAZODONE HCL 509 100
SEROQUEL XR 478 15
BENZTROPINE MESYLATE 459 42 R
OLANZAPINE 410 58
QUETIAPINE FUMARATE 370 37
LITHIUM CARBONATE 312 31
LAMOTRIGINE 312 40
BUPROPION HCL SR 274 55
ZIPRASIDONE HCL 264 0
ZOLPIDEM TARTRATE 227 47
FLUOXETINE HCL 220 24
PAROXETINE HCL 204 62
SERTRALINE HCL 198 42
CITALOPRAM HBR 196 66
DIVALPROEX SODIUM 193 0
DIVALPROEX SODIUM ER 168 26
CYMBALTA 164 45
SEROQUEL 153 12
TOPIRAMATE 145 0
VENLAFAXINE HCL ER 132 25
MIRTAZAPINE 109 40
GEODON 100 0
AMPHETAMINE SALT COMBO 98 0 S2
HALOPERIDOL 98 37
GABAPENTIN 95 0
AMITRIPTYLINE HCL 93 0 R
CARBAMAZEPINE 87 0
LATUDA 85 0
ESCITALOPRAM OXALATE 76 0
FLUPHENAZINE HCL 72 13
BUSPIRONE HCL 68 0
DEXTROAMPHETAMINE-AMPHETAMINE 67 0 S2
CLOZAPINE 66 0
PROPRANOLOL HCL 64 0
METHYLPHENIDATE HCL 63 18
INVEGA 61 0
ALPRAZOLAM 50 16
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.